The aim of the study was to detect the prevalence of human papillomavirus (HPV) infection in the upper respiratory tract of patients with laryngeal papillomatosis and evaluate outcomes of endolaryngeal microsurgery (EM).A group of 36 patients with laryngeal papillomatosis and a control group of 108 healthy individuals were examined for the presence of DNA of HPV. Viral typing using the polymerase chain reaction (PCR) was performed. DNA of HPV was detected in 35 out of 36 cases of laryngeal papillomatosis (97.22%), and only in 25 persons (23.15%) in the control group. HPV types 6 and 11 were predominant in these cases. A total of 89 patients, comprising of 32 subjects with juvenile papillomatosis (JP) and 57 with adult papillomas (AP), have been undergoing EM at the Department of Otolaryngology of Kaunas University of Medicine for the last 15 years. The recurrence rate in the follow-up period, lasting at least 2 years, was 72% (23 patients) in the JP group and 23% (13 patients) in the AP group. The number of EM for one patient ranged from 1 to 18 (mean 3.2) in the JP group and from 1 to 5 (mean 1.35) in the AP group. EM is a minimally invasive and safe technique, which provides accurate removal of papillomas. However, it remains as primarily palliative method of treatment.